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The construction of biohybrid devices in which motor proteins are integrated as
biomechanical components for powering nano- to microscale movement holds
great potential for a wide range of nanotechnological applications, ranging
from basic research to diagnostic lab-on-a-chip technologies. However, to op-
erate motor proteins efficiently in regard to cargo transport, sorting, and assem-
bly processes, it is important to control parameters such as velocity, motile ac-
tivity, force production, directionality, and processivity of movement tightly.
Long-term stability of the motor protein on synthetic environments is an addi-
tional prerequisite for their successful integration in biohybrid devices. Here we
describe a structure-based molecular engineering approach leading to the de-
sign and generation of two myosin constructs that maintain their motile activity
when immobilized on glass surfaces over greatly extended periods. Direct func-
tional assays and single molecule experiments show that important motor prop-
erties of the engineered nanomotors can be modulated by controlled changes in
buffer conditions. We show that the motile behavior of the dimeric M5P con-
struct can be switched between processive and non-processive modes of move-
ment and the motor activity of the monomeric M5S construct can be turned on
and off in a controlled, continuous, and reversible manner by coordinated
changes in the concentration of MgCl2 and KCl. The parametric control is
achieved accurately and with great ease. The resulting effects on motor func-
tion can be used for applications ranging from organising directed transport
with targeted accumulation of cargo as well as assembly and sensing functions
on the nano- to micro-scale levels.
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The immobilization of antigenic peptides in nanostructured films is promising
for the development of highly specific immunosensors. In this work, we ana-
lyze the peptide p17-1 (LSGGELDRWEKIRLRPGG), derived from the HIV-
1 p17 protein, immobilized into Layer-by-Layer (LbL) films and incorporated
into Langmuir monolayers of phospholipids. The LbL film was assembled us-
ing different polyelectrolytes but only poly(allylamine) hydrochloride (PAH)
was efficient for the peptide immobilization. The intensity in the UV-Vis. spec-
tra of PAH/p17-1 films increased exponentially with the number of layers,
which may indicate that the peptide can be reorganized in each bilayer ad-
sorbed. Fluorescence and circular dichroism (CD) spectra indicated that the in-
teraction with the film did not induce an alpha helix conformation in p17-1,
analogously to what occurs in an aqueous solution and in contrast to the orga-
nized peptide in a methanol solution. The maximum emission for p17-1 fluores-
cence occurred at 340 nm in methanol, compatible with tryptophan residue bur-
ied in the solvent, while for p17-1 in an LbL film the maximum appeared at 355
nm. This red shift is consistent with the tryptophan being exposed to the envi-
ronment. The CD spectra confirmed these results showing the random structure
for p17-1 in the LbL films and an a-helix structure in methanol solution. The
lack of structure is the probable reason for the low sensitivity toward anti-
p17 observed in amperometric sensors made with PAH/p17-1 LbL films.
With regard to the Langmuir monolayers, p17-1 was found to affect the surface
pressure isotherms of dipalmitoyl phosphatidyl glycerol (DPPG), even at a con-
centration as low as 0.5 mol%. This cooperative interaction of p17-1 and DPPG
may perhaps be exploited in designing new architectures for producing immu-
nosensors based on antigenic peptides.
3147-Pos
Engineering Hamlet-Like Proteins
Inmaculada Sanchez-Romero1, Asuncion Delgado-Delgado1,
Laura Lopez-Jimenez2, Javier Oliver Pozo2, Jose M. Sanchez-Ruiz1.
1Facultad de Ciencias, Dpto. de Quimica-Fisica, Universidad de Granada,
Granada, Spain, 2Instituto de Parasitologia y Biomedicina Lopez-Neyra,
CSIC, Granada, Spain.
It has been shown that a folding variant of alpha-lactalbumin containing oleic
acid (HAMLET: HumanAlpha-lactalbuminMade LEthal to tumor cells) induces
apoptosis in tumor cells whereas healthy cells remain resistant. Furthermore, theapoptotic activity of HAMLET seems related to fundamental physicochemical
features, such as the ability to populate partially unfolded conformations, likely
associated to a marginal folding/unfolding free-energy barrier. Here, we explore
the possibility of using protein engineering to create HAMLET-like behavior in
proteins other than alpha-lactalbumin. To this end, we have introduced in a suit-
able protein model system mutations that are expected to affect the thermody-
namic folding barrier and we have probed the oleic-acid binding capability of
the variants thus obtained. Finally, the tumoricidal activity of the resulting pro-
tein/oleic-acid complexes has been characterized.
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New high throughput methods of biophysical characterization of monoclonal
antibodies were developed to accelerate the process of pharmaceutical drug de-
velopment. The methods, thermostability screening, detection of aggregates
and viscosity measurements, can be performed in multi-well plate format,
and require low amounts of protein sample. A wide range of protein concentra-
tions including concentrations typically used in pharmaceutical formulations
can be studied. Case studies are presented and the results compared between
new and older techniques. We have shown that the new methods are fully com-
parable with previously used techniques such as differential scanning calorim-
etry, size exclusion chromatography and viscosity measurement by the cone
and plate method. The new methods have advantages of efficiency and high
throughput capability and could be widely applied in the biopharmaceutical in-
dustry for formulation and process development and characterization.
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The lipid composition of the eukaryotic plasma membrane is asymmetric; that
is, if the bilayer is considered to consist of two leaflets, the outer-facing leaflet
contains different lipids at different concentrations than the inner-facing leaflet.
While there has been much speculation as to the physiological purpose of this
asymmetry, it has been notoriously difficult to study in in vitro systems, since
synthetic artificial bilayer are difficult to form. This is especially true for giant
unilamellar vesicles (GUVs), which have been essential tools in studying lipid
mechanics and phase separation, but which are made from inherently symmet-
ric bilayers.
Here, we present a microfluidic technology that allows for the formation of
asymmetric GUVs. The vesicles are assembled in two independent steps. In
each step, a lipid monolayer is formed at a water-oil interface.. The first mono-
layer is formed inside of a microfluidic device with a multiphase droplet flow
configuration consisting of a continuous oil stream in which water droplets are
formed. Control over the flow parameters allows for control of droplet and, ul-
timately, vesicle size. Droplets are dispensed into a vessel containing a layer of
oil over a layer of water. The second lipid monolayer is formed by transferring
the droplets through this second oil-water interface using a spontaneous transfer
method. A density difference between the droplet interior and the aqueous sub-
phase drives this transfer. My dissolving different lipid compositions in the dif-
ferent lipid phases, and asymmetric membrane can be fabricated.
This method produces GUVs with controlled size, high stability , and compo-
sitional asymmetry. Asymmetry is demonstrated with a fluorescent quenching
assay, in which a membrane-impermeable chemical quenching agent is used to
quench fluorophores on only the exterior of the bilayer.
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Polyelectrolyte multilayers (PEMs) are promising materials for obtaining stable
and potentially functional supports for various biomimetic systems. Such films
may serve as highly hydrated cushions to comfort deposited biomembranes. In
this study we report new results from a continuous investigation of a polyelectro-
lyte multilayer system that is composed of alternating layers of chitosan and
